10 Stocks Register Strong Buy Signals in May 2026 Scan

May 2026 Scan Uncovers 10 Stocks with High-Confidence Buy Signals

The latest OpportunityRadar scan for May 01, 2026, reveals a compelling list of 10 stocks exhibiting strong technical and fundamental indicators, signaling potential opportunities. Leading the pack is Catalyst Pharmaceuticals, Inc. (CPRX), which boasts the highest OpportunityRadar Score of 81, driven by an exceptional fundamental score of 95. Close behind, FVCBankcorp, Inc. (FVCB) stands out with a STRONG BUY signal and 100% confidence, alongside a robust technical score of 85, making these two prominent entries in today's analysis.

Across the top 10 tickers identified, the scanner shows a strong alignment of positive signals. Nine out of these ten companies received a 100% confidence rating for their respective BUY or STRONG BUY signals, underscoring the conviction behind these entries. Furthermore, nine of the ten tickers display a MACD BULL signal, indicating positive momentum. The average Relative Strength Index (RSI) for this group stands at approximately 62.9, suggesting healthy upward movement without broadly entering overbought conditions. All ten tickers are flagged with a 'STRONG ENTRY' recommendation, reflecting the scanner's assessment of optimal timing.

Top 10 Signals at a Glance

#1: CPRX — Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals, Inc. (CPRX) stands out at the top of today's scan with an impressive OpportunityRadar Score of 81. This score is underpinned by a robust fundamental rating of 95, complemented by a strong technical score of 71. The system issues a clear BUY signal with 100% confidence, indicating a STRONG ENTRY point. Technical indicators support this positive outlook, with the Relative Strength Index (RSI) at 63.6, suggesting healthy upward momentum without being in overbought territory, and the Moving Average Convergence Divergence (MACD) signal firmly in BULL territory. The stock has demonstrated solid performance, posting a 14.18% gain over the last month and a 12.76% increase over the past three months.

While the overall picture for CPRX is strong, the Risk/Reward ratio of 1.5, while positive, is not the highest observed in the scan. This suggests that potential upside might be less pronounced relative to the risk compared to other opportunities with higher ratios, such as FVCB or ORKA, both of which are rated at 2.0.

#2: FVCB — FVCBankcorp, Inc.

FVCBankcorp, Inc. (FVCB) registers an OpportunityRadar Score of 70, propelled by a strong technical score of 85. The scanner has issued a STRONG BUY signal for FVCB, backed by a 100% confidence rating and a STRONG ENTRY recommendation. Technical analysis indicates positive momentum, with the RSI at 60.6 and the MACD signal in BULL territory. The stock has shown modest but positive returns over the past periods, with a 3.68% gain in the last month and a 1.68% increase over the last three months. Notably, FVCB presents an appealing Risk/Reward ratio of 2.0, which is among the highest in this scan, suggesting a favorable balance between potential gains and associated risks.

Despite strong technicals, FVCB's fundamental score of 47 is considerably lower than its technical score of 85. This disparity suggests that the current BUY signal is predominantly driven by technical strength, and investors relying solely on fundamental analysis might find less corroborating data within the scanner's provided metrics.

#3: UNP — Union Pacific Corporation

Union Pacific Corporation (UNP) comes in with an OpportunityRadar Score of 67, reflecting a technical score of 73 and a fundamental score of 58. The stock has received a BUY signal with a perfect 100% confidence rating and a STRONG ENTRY indication. Technical indicators are aligned positively, with the RSI at 63.4, suggesting a healthy upward trend, and the MACD signal firmly in BULL territory. UNP has demonstrated consistent positive performance, with an 8.90% return over the last month and a notable 13.29% gain over the last three months, indicating sustained upward momentum in its price action.

A key factor to consider for UNP is its relatively low Risk/Reward ratio of 0.3. This ratio implies that the potential upside from the current entry point may be limited compared to the potential downside, suggesting a less attractive risk-adjusted return profile when compared to other opportunities in the scan with higher ratios.

#4: SEI — Solaris Energy Infrastructure,

Solaris Energy Infrastructure (SEI) shows an OpportunityRadar Score of 67, with a technical score of 74 and a fundamental score of 56. The scanner has identified SEI with a BUY signal, accompanied by a 100% confidence level and a STRONG ENTRY recommendation. From a technical perspective, the RSI stands at 64.8, indicating strong buying interest, and the MACD signal is in BULL territory, reinforcing the positive momentum. SEI has delivered exceptional performance, recording a substantial 31.20% return over the last month and an impressive 28.82% gain over the past three months, positioning it as a significant recent gainer within this scan.

While SEI's recent returns are very strong, its overall OpportunityRadar Score of 67 is moderate compared to its impressive short-term performance. This could suggest that while momentum is currently robust, other underlying factors contributing to the aggregated score might not be as strong, warranting a closer look at the balance of technical and fundamental components.

#5: CSX — CSX Corporation

CSX Corporation (CSX) holds an OpportunityRadar Score of 66, with its technical score at 71 and fundamental score at 58. The scanner has issued a BUY signal with 100% confidence and a STRONG ENTRY recommendation. Technical indicators for CSX are positive, featuring an RSI of 64.7, suggesting solid upward price action, and a MACD signal that is BULL. The stock has posted healthy returns, gaining 9.69% over the last month and an even stronger 17.78% over the past three months, indicating a sustained positive trend in its valuation.

Similar to other entries in this scan, CSX's Risk/Reward ratio of 0.3 is notably low. This figure suggests that the potential for further upside might be constrained relative to the inherent risks, which could make it less appealing for investors seeking opportunities with a more favorable risk-adjusted return profile.

#6: NSC — Norfolk Southern Corporation

Norfolk Southern Corporation (NSC) is featured with an OpportunityRadar Score of 66, comprising a technical score of 71 and a fundamental score of 58. The scanner indicates a BUY signal for NSC, supported by a 100% confidence rating and a STRONG ENTRY recommendation. Technical analysis shows the RSI at 64.2, reflecting healthy buying interest, and the MACD signal is in BULL territory, confirming positive momentum. NSC has delivered consistent positive returns, with a 9.82% gain over the last month and an 8.52% increase over the past three months.

NSC presents the lowest Risk/Reward ratio in this top 10 list, at 0.2. This particularly low ratio indicates a very limited potential for upside relative to the associated risk, suggesting that the stock might not offer a compelling risk-adjusted return compared to other opportunities with higher Risk/Reward metrics.

#7: LGND — Ligand Pharmaceuticals Incorpo

Ligand Pharmaceuticals Incorporated (LGND) has an OpportunityRadar Score of 65, with a technical score of 71 and a fundamental score of 56. The scanner has assigned a BUY signal to LGND, accompanied by a 100% confidence level and a STRONG ENTRY recommendation. Technical indicators are favorable, with the RSI at 60.2, indicating room for continued upward movement, and the MACD signal in BULL territory. LGND has shown strong recent performance, with a 17.22% return over the last month and an 18.20% gain over the past three months, demonstrating solid price appreciation.

The Risk/Reward ratio for LGND stands at 0.6. While not as low as some other entries, it still suggests a moderate risk-adjusted return profile. Investors prioritizing opportunities with a higher potential upside relative to risk might find this ratio less attractive compared to tickers with a 2.0 Risk/Reward ratio.

#8: DXPE — DXP Enterprises, Inc.

DXP Enterprises, Inc. (DXPE) registers an OpportunityRadar Score of 65, supported by a technical score of 71 and a fundamental score of 56. The scanner has issued a BUY signal for DXPE, backed by a 100% confidence rating and a STRONG ENTRY recommendation. Technical indicators are robust, with the RSI at 62.9, suggesting healthy buying momentum, and the MACD signal in BULL territory. DXPE has delivered strong returns over recent periods, posting a 16.67% gain in the last month and an impressive 24.40% increase over the past three months, indicating a sustained positive trend.

DXPE's Risk/Reward ratio is 0.4, which is on the lower side among the stocks in this scan. This implies that while the stock has shown strong recent performance, the potential for future gains relative to the risk involved may be somewhat limited, suggesting a cautious approach for those focused on risk-adjusted returns.

#9: ORKA — Oruka Therapeutics, Inc.

Oruka Therapeutics, Inc. (ORKA) shows an OpportunityRadar Score of 65, with a technical score of 73 and a fundamental score of 53. The scanner has issued a BUY signal for ORKA, though with a slightly lower confidence rating of 83% compared to most others in the top 10. It still indicates a STRONG ENTRY point. ORKA has delivered exceptional returns, with a 20.37% gain over the last month and a remarkable 87.08% increase over the past three months. The stock also boasts a high Risk/Reward ratio of 2.0, suggesting a favorable balance of potential upside versus risk.

A notable technical divergence for ORKA is its MACD signal, which is BEAR, despite the overall BUY signal and strong recent price performance. This bearish MACD, coupled with an RSI of 54.1 (lower than most bullish signals in the scan), indicates a potential weakening of momentum or a shift in trend that warrants careful monitoring, especially given the 83% confidence rating which is not 100%.

#10: NWBI — Northwest Bancshares, Inc.

Northwest Bancshares, Inc. (NWBI) rounds out our top 10 with an OpportunityRadar Score of 64, featuring a technical score of 70 and a fundamental score of 56. The scanner has issued a BUY signal for NWBI with a 100% confidence rating and a STRONG ENTRY recommendation. Technical indicators are positive, with the RSI at 63.2, suggesting healthy buying interest, and the MACD signal in BULL territory. The stock has shown consistent positive returns, with a 7.53% gain over the last month and a 6.62% increase over the past three months.

The Risk/Reward ratio for NWBI is 0.3, placing it among the lower ratios in this scan. This indicates that the potential for upside may be limited relative to the risk involved, suggesting that investors focused on maximizing risk-adjusted returns might find other opportunities in the scan more compelling.

Key Observations Across the Scan

The May 2026 OpportunityRadar scan highlights a strong bullish sentiment across the profiled stocks. A significant observation is that 9 out of the 10 tickers featured received a 100% confidence rating, indicating high conviction behind the BUY or STRONG BUY signals. Similarly, 9 out of 10 tickers show their MACD signal in BULL territory, underscoring broad positive momentum. The average RSI across these 10 stocks is approximately 62.9, suggesting that while momentum is strong, most are not yet in extreme overbought conditions. Furthermore, six of the ten tickers demonstrated substantial short-term strength, with 1-month returns exceeding 10%, including SEI (31.20%), ORKA (20.37%), LGND (17.22%), DXPE (16.67%), CPRX (14.18%), and HCSG (15.37% - though HCSG is #11, not in this top 10 list). SEI and ORKA also showed exceptional 3-month returns of 28.82% and 87.08% respectively. All 10 tickers were given a 'STRONG ENTRY' recommendation.

Key Risk Factors

• MACD Divergence for ORKA: Oruka Therapeutics, Inc. (ORKA) shows a MACD BEAR signal despite receiving a BUY signal and exhibiting strong 1-month (20.37%) and 3-month (87.08%) returns. This divergence between recent price performance and the MACD indicator, coupled with an 83% confidence rating (lower than the 100% seen in most other top signals), suggests a potential shift in momentum that warrants close monitoring.
• Low Risk/Reward Ratios: Several tickers in this scan present notably low Risk/Reward ratios, indicating a potentially limited upside relative to the inherent risk. Specifically, NSC (0.2), UNP (0.3), CSX (0.3), and NWBI (0.3) have ratios below 0.5. This suggests that the potential return for each unit of risk taken is relatively small, which may not align with all investment strategies.
• Missing Fundamental Data: For all tickers in the scan, key fundamental metrics such as P/E, EPS, Debt/Equity, and earnings/revenue growth are listed as N/A. This absence of granular fundamental data means that the OpportunityRadar Score and subsequent BUY signals are heavily reliant on technical indicators and the aggregated fundamental component score. Investors should be aware of this data limitation and consider conducting further fundamental research if such metrics are critical to their decision-making process.

About Our Methodology

OpportunityRadar scans 6,600+ US stocks daily using 15+ technical indicators including RSI, MACD, Bollinger Bands, ADX, Aroon, support/resistance levels, and volume analysis, combined with fundamental metrics. Stocks are scored 0-100 with signals ranging from Accumulate to Strong Buy. Entry confidence is rated 50-100% based on 6 confirmation factors.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. Past performance does not guarantee future results. Always conduct your own research and consult a qualified financial advisor before making investment decisions. Data as of May 01, 2026.